Your browser doesn't support javascript.
loading
Screening of over 1000 Indian patients with breast and/or ovarian cancer with a multi-gene panel: prevalence of BRCA1/2 and non-BRCA mutations.
Singh, Jaya; Thota, Nishita; Singh, Suhasini; Padhi, Shila; Mohan, Puja; Deshwal, Shivani; Sur, Soumit; Ghosh, Mithua; Agarwal, Amit; Sarin, Ramesh; Ahmed, Rosina; Almel, Sachin; Chakraborti, Basumita; Raina, Vinod; DadiReddy, Praveen K; Smruti, B K; Rajappa, Senthil; Dodagoudar, Chandragouda; Aggarwal, Shyam; Singhal, Manish; Joshi, Ashish; Kumar, Rajeev; Kumar, Ajai; Mishra, Deepak K; Arora, Neeraj; Karaba, Aarati; Sankaran, Satish; Katragadda, Shanmukh; Ghosh, Arunabha; Veeramachaneni, Vamsi; Hariharan, Ramesh; Mannan, Ashraf U.
Afiliação
  • Singh J; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Thota N; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Singh S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Padhi S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Mohan P; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Deshwal S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Sur S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Ghosh M; Triesta Sciences, Health Care Global Enterprises Limited, Bangalore, India.
  • Agarwal A; BLK Super Specialty Hospital, Delhi, India.
  • Sarin R; Indraprastha Apollo Hospitals, Delhi, India.
  • Ahmed R; Tata Medical Center, Kolkata, India.
  • Almel S; P. D. Hinduja Hospital and Medical Research Centre, Mumbai, India.
  • Chakraborti B; Tata Medical Center, Kolkata, India.
  • Raina V; Fortis Healthcare, Gurgaon, India.
  • DadiReddy PK; Continental Hospitals, Hyderabad, India.
  • Smruti BK; Bombay Hospital and Medical Research Centre, Mumbai, India.
  • Rajappa S; Basavatarakam Indo American Cancer Hospital and Research Institute, Hyderabad, India.
  • Dodagoudar C; BLK Super Specialty Hospital, Delhi, India.
  • Aggarwal S; Sir Ganga Ram Hospital, Delhi, India.
  • Singhal M; Indraprastha Apollo Hospitals, Delhi, India.
  • Joshi A; Nanavati Super Specialty Hospital, Mumbai, India.
  • Kumar R; Rajiv Gandhi Cancer Institute and Research Centre, Delhi, India.
  • Kumar A; Health Care Global Enterprises Limited, Bangalore, India.
  • Mishra DK; Tata Medical Center, Kolkata, India.
  • Arora N; Tata Medical Center, Kolkata, India.
  • Karaba A; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Sankaran S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Katragadda S; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Ghosh A; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Veeramachaneni V; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Hariharan R; Strand Center for Genomics and Personalized Medicine, Strand Life Sciences, Kirloskar Business Park, Bellary Road, Hebbal, Bangalore, 560024, India.
  • Mannan AU; Department of Computer Science and Automation, Indian Institute of Science, Bangalore, India.
Breast Cancer Res Treat ; 170(1): 189-196, 2018 Jul.
Article em En | MEDLINE | ID: mdl-29470806
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_muertes_prematuras_enfermedades_notrasmisibles Assunto principal: Neoplasias da Mama / Proteína Supressora de Tumor p53 / Proteína BRCA1 / Proteína BRCA2 / Proteína do Grupo de Complementação N da Anemia de Fanconi Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Índia
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Contexto em Saúde: 2_ODS3 Problema de saúde: 2_muertes_prematuras_enfermedades_notrasmisibles Assunto principal: Neoplasias da Mama / Proteína Supressora de Tumor p53 / Proteína BRCA1 / Proteína BRCA2 / Proteína do Grupo de Complementação N da Anemia de Fanconi Tipo de estudo: Diagnostic_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limite: Adult / Aged / Female / Humans / Middle aged País/Região como assunto: Asia Idioma: En Revista: Breast Cancer Res Treat Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Índia